Brief: Index Pharmaceuticals Says Will Initiate Patient Recruitment For The Phase III Study CONCLUDE After The Summer

Flerie AB

31/05/2021 18:24

May 31 (Reuters) - InDex Pharmaceuticals Holding AB
 INDEX.ST :
    * INDEX PHARMACEUTICALS WILL INITIATE PATIENT RECRUITMENT
FOR THE
PHASE III STUDY CONCLUDE AFTER THE SUMMER
    * INDEX PHARMACEUTICALS-STUDY WILL EVALUATE EFFICACY&SAFETY
OF
DRUG CANDIDATE COBITOLIMOD FOR TREATMENT OF MODERATE-SEVERE
LEFT-SIDED ULCERATIVE COLITIS
    * INDEX PHARMACEUTICALS HOLDING AB - PROCESS OF APPLYING FOR
AND
OBTAINING APPROVAL FROM RELEVANT AUTHORITIES IN PARTICIPATING
COUNTRIES IS ONGOING

Source text for Eikon:  ID:nWkr3pN9vG 
Further company coverage:  INDEX.ST 

 ((Reuters.Briefs@thomsonreuters.com;))